Clinical Trial: A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1596 Tablets in Healthy Participants With a Single Dose and in Obese Participants With Multiple Doses

U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07841860) titled 'A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1596 Tablets in Healthy Participants With a Single Dose and in Obese Participants With Multiple Doses' on Sept. 21.

Brief Summary: This study is a randomized, double-blind, placebo-controlled, dose-escalation study that examines the safety, tolerability, pharmacokinetics and pharmacodynamics in healthy participants and multiple administrations in obese participants.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Weight Management Type 2 Diabetes

Intervention: DRUG: HRS-1596

HRS-1596.

DRUG: HRS-1596 Placebo

HRS-1596 placeb...